tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RDHL Stock Latest News

RedHill Biopharma Reports 2024 Financial Results and Strategic Advances
Company AnnouncementsRedHill Biopharma Reports 2024 Financial Results and Strategic Advances
2h ago
6K
RDHL
RedHill Biopharma Announces Board Resignation of Eric Swenden
PremiumCompany Announcements
RedHill Biopharma Announces Board Resignation of Eric Swenden
2d ago
6K
RDHL
RedHill Biopharma Announces Agenda for 2025 Annual General Meeting
PremiumCompany Announcements
RedHill Biopharma Announces Agenda for 2025 Annual General Meeting
9d ago
6K
RDHL
RedHill Biopharma Announces Annual General Meeting Agenda
PremiumCompany Announcements
RedHill Biopharma Announces Annual General Meeting Agenda
15d ago
6K
RDHL
RedHill Biopharma to Seek UK Approval for Talicia
PremiumCompany Announcements
RedHill Biopharma to Seek UK Approval for Talicia
23d ago
6K
RDHL
RedHill Biopharma to submit UK MAA for Talicia
PremiumThe FlyRedHill Biopharma to submit UK MAA for Talicia
23d ago
RDHL
RedHill Biopharma Advances Crohn’s Disease Program with New Study
Premium
Company Announcements
RedHill Biopharma Advances Crohn’s Disease Program with New Study
29d ago
6K
RDHL
RedHill Biopharma announces plans to advance program for Crohn’s disease
Premium
The Fly
RedHill Biopharma announces plans to advance program for Crohn’s disease
29d ago
RDHL
RedHill Biopharma Highlights Strategic Advances at European Forum
PremiumCompany Announcements
RedHill Biopharma Highlights Strategic Advances at European Forum
1M ago
6K
RDHL
RedHill Biopharma provides business update on RHB-102, 2025 catalysts
PremiumThe Fly
RedHill Biopharma provides business update on RHB-102, 2025 catalysts
1M ago
RDHL
RedHill Biopharma Licenses RHB-102 to Hyloris for Global Markets
PremiumCompany Announcements
RedHill Biopharma Licenses RHB-102 to Hyloris for Global Markets
1M ago
6K
RDHL
RedHill Biopharma licenses RHB-102 for global commercialization to Hyloris
PremiumThe Fly
RedHill Biopharma licenses RHB-102 for global commercialization to Hyloris
1M ago
RDHL
RedHill Biopharma Initiates Phase 2 Study on Prostate Cancer Treatment
PremiumCompany AnnouncementsRedHill Biopharma Initiates Phase 2 Study on Prostate Cancer Treatment
2M ago
6K
RDHL
RedHill Biopharma begins Phase 2 study of prostate cancer combination
Premium
The Fly
RedHill Biopharma begins Phase 2 study of prostate cancer combination
2M ago
RDHL
RedHill Biopharma Engages in Strategic Market Offering to Boost Financial Flexibility
Premium
Company Announcements
RedHill Biopharma Engages in Strategic Market Offering to Boost Financial Flexibility
2M ago
6K
RDHL
RedHill Biopharma Expands Medicare Coverage and Simplifies Talicia Dosing
PremiumCompany Announcements
RedHill Biopharma Expands Medicare Coverage and Simplifies Talicia Dosing
3M ago
6K
RDHL
RedHill Biopharma’s Talicia now covered by Humana’s Part D Plan
PremiumThe Fly
RedHill Biopharma’s Talicia now covered by Humana’s Part D Plan
3M ago
RDHL
RedHill Biopharma Advances Opaganib for GI-ARS Treatment
PremiumCompany Announcements
RedHill Biopharma Advances Opaganib for GI-ARS Treatment
4M ago
6K
RDHL
RedHill Biopharma’s opaganib shows radioprotective activity in study
PremiumThe Fly
RedHill Biopharma’s opaganib shows radioprotective activity in study
4M ago
RDHL
RedHill Biopharma Wins $8 Million Court Judgment
PremiumCompany AnnouncementsRedHill Biopharma Wins $8 Million Court Judgment
4M ago
6K
RDHL
RedHill Biopharma awarded judgement of approx $8M by NY Supreme Court
Premium
The Fly
RedHill Biopharma awarded judgement of approx $8M by NY Supreme Court
4M ago
RDHL
RedHill Biopharma to Present Opaganib at U.S. Defense Conference
Premium
Company Announcements
RedHill Biopharma to Present Opaganib at U.S. Defense Conference
5M ago
6K
RDHL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >